Fujfilm Medical Systems USA parent Fujifilm has inked a definitive agreement to acquire the Merck BioManufacturing Network, which provides contract manufacturing and development services for the biopharmaceutical industry.
With an eye on expanding its pharmaceutical business, Fujifilm will buy all of the equity interests in two Merck subsidiaries -- Diosynth RTP and MSD Biologics -- that together own all assets of the Merck BioManufacturing Network. The network comprises Diosynth facilities located in Research Triangle Park, NC, and MSD Biologics facilities in Billingham, U.K.
The agreement includes manufacturing contracts, business support operations, and Merck BioManufacturing Network's workforce. As part of the agreement, Whitehouse Station, NJ-based Merck (known outside the U.S. and Canada as MSD) has committed to certain continued development and manufacturing activities with these two companies, Fujifilm said.
Financial details were not disclosed.
